The NU 670 Unit 2 table, complete: every agent matched to its clearance route, its own inhibiting or inducing behavior, and the consequence when two agents share a route. Searches like "nu 670 unit 2 assignment example", "nu670 unit 2 sample" and "nu 670 unit 2 example" land here.
What a finished NU 670 Unit 2 clearance pathway table looks like
The finished table is narrow and heavily footnoted. Rows are agents, and columns hold the principal enzyme or transporter responsible for removal, secondary routes, whether the agent itself inhibits or induces, and whether a known genetic variant in that enzyme shifts exposure. Underneath sits the part carrying the grade: short entries walking through the pairs that share a route, saying which direction exposure moves and what would be watched as a result. Prodrugs get a note of their own, since an inhibited prodrug loses effect while an inhibited active agent gains exposure, and treating both as one case is the error this unit watches for. Every row cites the label or pharmacokinetic source it came from, with the revision recorded beside it.
How a NU 670 Unit 2 example is structured
The example is arranged so a row can be checked against its source without reading the prose around it. It opens with scope: which agents are included, why those, and what the table deliberately leaves out, because a grid covering every marketed psychotropic is a reference work rather than an argument. Route columns follow in a fixed order, principal before secondary, so no row quietly reports a minor pathway as the main one. Inhibition and induction occupy columns separate from clearance itself, since an agent removed by one enzyme while inhibiting another is the ordinary case and collapsing the two produces nonsense. The narrative then handles pairs one at a time, direction of change stated ahead of any consequence. Induction timing closes the document, as it builds and resolves on a slower clock than inhibition.
Principal route separated from secondary
Columns keep the main clearance pathway apart from minor contributors, so a row cannot present a small one as though it removed the agent.
Inhibition kept apart from clearance
An agent removed by one enzyme while inhibiting another is ordinary, and a single column holding both makes the entire row unreadable.
Direction of exposure stated for every pair
Each shared route says whether exposure rises or falls, since a paired interaction with no direction attached leaves a reader nothing usable.
Prodrugs flagged ahead of everything
Agents requiring conversion are marked early, because inhibition removes their effect while it raises exposure to agents that arrive already active.
Induction given a clock of its own
Enzyme induction is described as building and resolving over a longer span than inhibition, which readers commonly assume runs on one timescale.
Sources cited down to the revision
Every row names the label or study behind it and the revision date, since these values are corrected more often than writers expect.
Where marks go in NU 670 Unit 2
The commonest deduction on this deliverable is a grid with no narrative beneath it. Rows of enzyme names prove nothing about reasoning, and a criterion looking for analysis has only the table to read. Reversal is the next and more serious failure: writing that an inhibitor lowers exposure to the agent it inhibits inverts the entry and usually inverts whatever follows from it. Papers treating every shared route as clinically important lose accuracy, since many overlaps shift exposure by an amount nobody would act on, and saying so is part of the work. Genetic variation mentioned as a phrase, with no enzyme and no direction, adds length and no substance. Undated sources undermine the table entirely, because pharmacokinetic values do not stay still.
Get a NU 670 Unit 2 example written to your instructions
Send the Unit 2 instructions and the rubric from your NU 670 classroom, along with the agents the table should hold. We write a custom example with principal and secondary routes separated, inhibition and induction in their own columns, every shared pair given a direction, and each row sourced to a dated revision. First custom sample free, returned in 24 to 48 hours.
NU 670 Unit 2 questions, answered
How many agents should the table hold?
Few enough that every row can be sourced and discussed, which usually means four to eight rather than a whole formulary. A short table with real narrative under it outperforms a long one nobody could verify, and the instructions often cap the number anyway. Where a class shares a route, one representative plus a sentence about the class covers more ground than three near-identical rows.
Does the table need pharmacogenomic columns?
Only where the instructions ask for them, and then handled carefully. Naming the enzyme, the direction a variant shifts exposure, and whether testing is routinely available is enough for an academic table. What a result would mean for one person is a clinical judgment resting on current labeling and your own board, and an example is not where that question gets settled.
Do non-psychiatric medicines belong in it?
More often than not, since these routes are shared with cardiac agents, anti-infectives, anticonvulsants and several products sold without a prescription. A table confined to psychotropic pairs misses the overlaps that actually turn up on a medication list. Hold the non-psychiatric rows to the same sourcing standard as the rest, and note where the evidence for one of them is thin.